Kiromic Biopharma Inc.

04/24/2024 | Press release | Distributed by Public on 04/24/2024 06:31

Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients